TL 383 TL 383 Pill - gray capsule/oblong, 16mm
Pill with imprint TL 383 TL 383 is Gray, Capsule/Oblong and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Cadista.
Terazosin is used in the treatment of Benign Prostatic Hyperplasia; High Blood Pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 383 TL 383
Terazosin Hydrochloride
- Imprint
- TL 383 TL 383
- Strength
- 1 mg
- Color
- Gray
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista
- Inactive Ingredients
-
ferrosoferric oxide,
gelatin,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
corn starch,
silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0383 | Jubilant Cadista Pharmaceuticals Inc. |
| 67544-0581 | Prepak Systems Inc. (repackager) |
Related images for "TL 383 TL 383"
More about terazosin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (50)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alpha-adrenoreceptor antagonists
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
